10.1371/journal.pone.0081339 26 ChuS
Purity : 99% (HPLC Certified) Form: Lyophilized powder Appearance: White to off-white powder Solubility: Soluble in laboratory-grade sterile water COA: Included in product image gallery This peptide analog is supplied strictly for laboratory research
These 3 powerful antioxidants, when used in combination, is one of the best natural ways to cleanse the body
Home Products Health Supplement L-Glutathione, Vitamin-C and Alpha Lipoic Acid Tablet L-Glutathione, Vitamin-C and Alpha Lipoic Acid Tablet Specification Efficacy Other Medicine Type Nutraceutical Effect Supports Skin Radiance, Antioxidant Defense & Overall Skin Heal Life Span 18 months Origin India Chemical Composition L-Glutathione + Vitamin C + Alpha Lipoic Acid Strength L-Glutathione 500 mg Vitamin C 40 mg Alpha Lipoic Acid 50 mg Shelf Life 18 Months Brand Name oem private label Ingredients L-Glutathione, Vitamin C, Alpha Lipoic Acid Function Antioxidant Dosage 1 Tablet Daily or As Directed by Healthcare Professional Dosage Guidelines With Water Dosage Form Tablet Storage Instructions Store in a Cool & Dry Place Away from Direct Sunlight Packaging Size 10x10 Tablets / 30 Tablets / 60 Tablets Packaging Type Blister Pack / HDPE Jar L-Glutathione, Vitamin-C and Alpha Lipoic Acid Tablet Trade Information Minimum Order Quantity 3000 Packs Payment Terms Cash in Advance (CID) Supply Ability 500000 Packs Per Month Delivery Time 25 Days Packaging Details 10x10 Tablets Blister Pack or HDPE Jar Packaging with Printed Carton
monitor blood glucose closely Symptoms of low blood sugar (shakiness, sweating, confusion) especially peri-workout or when fasted Injection site reactions (redness, bruising, discomfort) Theoretical growth-pathway concerns from strong IGF-1 receptor activation Risk of additive hypoglycemia when combined with insulin or other IGF-axis compounds avoid casual stacking Human safety is not established research-only and not FDA-approved IGF-1 DES (des(1-3)IGF-1) is a truncated 67-amino-acid analog of insulin-like growth factor-1 missing the N-terminal Gly-Pro-Glu tripeptide
Future treatment strategies should be based on a global perspective of the aging regulatory network: on the one hand, core regulatory nodes across pathways should be screened through systematic biological analysis
